- 1Institute of Biomedical Research Cadiz (INIBICA), Cádiz, Spain
- 2Department of Biomedicine, Biotechnology and Public Health (Immunology), University of Cádiz, Cádiz, Spain
- 3Biogipuzkoa Health Research Institute, Molecular Oncology Group, San Sebastián, Spain
- 4Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom
Editorial on the Research Topic:
Mechanisms of early intracellular signaling in T lymphocytes
T cells are central orchestrators of adaptive immunity, initiating antigen-specific responses that protect against infection and maintain immune surveillance. They recognize antigens via precise interactions between their T cell receptors (TCRs) and peptide-major histocompatibility complexes (pMHCs) on antigen-presenting cells (APCs). These interactions trigger intracellular signaling cascades that regulate T cell development, activation, and effector function.
The tight regulation of early TCR signaling is essential for mounting effective immune responses while preventing excessive or chronic activation. Upon antigen recognition, the Src-family kinase Lck is recruited to the TCR complex—particularly the CD3ε subunit—and phosphorylates ITAM motifs in the CD3 subunits. This creates docking sites for ZAP70, which activates itself and promotes downstream signaling, including LAT signalosome assembly (1). Disruption of LAT signalosome kinetics can impair T cell activation and development (2, 3). Along the same line, endocytic trafficking further shapes TCR signaling outcomes. Flotillin-mediated recycling affects nanoclustering of surface TCRs, promoting sustained signaling (4). In contrast, ESCRT proteins HRS and STAM2 mediate TCR release in extracellular vesicles via ectocytosis, contributing to signal termination (5). Thus, early TCR signaling involves key kinases (Lck, Fyn, ZAP70), phosphatases (CD45), adaptor proteins (LAT), and trafficking regulators (Flotillin, HRS, STAM), which together modulate signal strength and duration to fine-tune T cell responses (6). This Research Topic includes two review articles and two original research papers, exploring recent advances in early intracellular TCR signaling with emphasis on activation mechanisms and negative regulation.
Qin and Xu review how TCR signaling strength, duration, and integration with co-stimulation, cytokines, and metabolic cues influence T cell lineage decisions. For instance, they discuss recent work that found strong TCR signals to suppress the transcription factor KLF2, essential for maintaining effector lineage fidelity. Genetic deletion of KLF2 skews cells toward an exhausted-like phenotype. Their review also highlights TCR-driven control of Treg versus Th17 fate: robust signaling promotes Th17 differentiation via Lck/Fyn-STAT3 and MALT1-mediated cleavage of Roquin and Regnase-1—post-transcriptional repressors of Th17 genes. In contrast, engineered TCRs with non-signaling ITAMs reduce signaling strength and favor Treg differentiation, emphasizing how TCR signal tuning influences immune balance.
Along these lines, Love et al. present a comprehensive review of ITAM function, highlighting three primary models: signal discrimination, signal amplification, and signal duality. Recent studies, including their own, show that certain ITAMs can deliver both activating and inhibitory signals depending on pMHC affinity and subunit context. This duality contributes to ligand discrimination and immune modulation, offering a mechanistic explanation for ligand-mediated antagonism—a long-standing mystery in TCR biology. These insights support a more refined view of TCR regulation and may inform strategies for enhancing or suppressing T cell responses.
Calcium (Ca²+) fluxes are critical regulators of T cell activation, differentiation, and fate decisions. In this context, Schreiber et al. explore the role of anoctamin 9 (ANO9), a Ca²+-activated chloride channel, in regulating TCR-induced Ca²+ signaling. Ca²+ entry is mainly mediated by store-operated ORAI1 channels, coordinated by STIM1 and PIP2. ANO9 helps recruit Ca²+-ATPases to the plasma membrane, maintaining optimal Ca²+ levels near ORAI1 channels and preventing inhibition of store-operated Ca²+ entry (SOCE). This positions ANO9 as a critical modulator of early TCR signaling. Functional studies in Jurkat T cells and primary lymphocytes confirm its role in Ca²+ signal initiation, suggesting ANO9 as a potential target for tuning T cell activation in immune disorders.
Kim et al. present original research on ARAP, a novel adaptor protein implicated in TCR signaling and integrin-mediated adhesion. ARAP-deficient T cells exhibit impaired phosphorylation of key signaling molecules, including PLC-γ1, SLP-76, Akt, and ERK, resulting in reduced activation, proliferation, and cytokine production. In a mouse model of experimental autoimmune encephalomyelitis (EAE), ARAP-deficient mice show lower IFN-γ levels and milder disease, underscoring ARAP’s essential role in T cell-mediated immune responses. This protein emerges as a promising candidate for therapeutic modulation in autoimmunity.
While TCR signaling has been studied for decades, it continues to yield new insights that reshape our understanding of T cell regulation. The studies featured in this Research Topic illuminate critical components of early TCR signaling: the dual roles of ITAMs in fine-tuning signal output, ANO9’s control of Ca²+ dynamics, and ARAP’s integration of TCR and adhesion signals. Each discovery offers new therapeutic angles for immune modulation.
These findings collectively underscore the complexity and plasticity of TCR-proximal signaling. Feedback mechanisms, signal modulators, and membrane trafficking elements all converge to calibrate TCR responses. Such precision is key not only for immune homeostasis but also for effective interventions in cancer, infection, and autoimmunity.
Moving forward, unraveling how these signaling pathways are integrated will be critical for understanding T cell fate decisions and for developing precision immunotherapies. Mechanistic insights into early TCR events may enable the rational design of enhanced CAR-T cells, novel checkpoint inhibitors, and modulators that preserve immune balance while boosting specific responses—for example, against tumors.
Author contributions
EA: Writing – review & editing, Writing – original draft. MA-E: Writing – review & editing, Writing – original draft. EC: Writing – review & editing, Writing – original draft.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. EA is funded by the Agencia Estatal de Investigación (Ministerio de Ciencia e Innovación, Spain, grant PID2020-113943RB-I00 to EA), and by Consejerıá de Transformación Económica, Industria, Conocimiento y Universidades (Junta de Andalucıá, Spain, grant P20_01297 to EA). EC is supported by John Fell Fund, and ERC_2021_SyG 951329-ATTACK to Michael Dustin.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Fernandez-Aguilar LM, Vico-Barranco I, Arbulo-Echevarria MM, and Aguado E. A story of kinases and adaptors: the role of lck, ZAP-70 and LAT in switch panel governing T-cell development and activation. Biol (Basel). (2023) 12:1169. doi: 10.3390/biology12091163
2. Arbulo-Echevarria MM, Vico-Barranco I, Zhang F, Fernandez-Aguilar LM, Chotomska M, Narbona-Sanchez I, et al. Mutation of the glycine residue preceding the sixth tyrosine of the LAT adaptor severely alters T cell development and activation. Front Immunol. (2022) 13:1054920. doi: 10.3389/fimmu.2022.1054920
3. Lo WL, Kuhlmann M, Rizzuto G, Ekiz HA, Kolawole EM, Revelo MP, et al. A single-amino acid substitution in the adaptor LAT accelerates TCR proofreading kinetics and alters T-cell selection, maintenance and function. Nat Immunol. (2023) 24:676–89. doi: 10.1038/s41590-023-01444-x
4. Compeer EB, Kraus F, Ecker M, Redpath G, Amiezer M, Rother N, et al. A mobile endocytic network connects clathrin-independent receptor endocytosis to recycling and promotes T cell activation. Nat Commun. (2018) 9:1597. doi: 10.1038/s41467-018-04088-w
5. Kvalvaag A, Valvo S, Cespedes PF, Saliba DG, Kurz E, Korobchevskaya K, et al. Clathrin mediates both internalization and vesicular release of triggered T cell receptor at the immunological synapse. Proc Natl Acad Sci U.S.A. (2023) 120:e2211368120. doi: 10.1073/pnas.2211368120
Keywords: TCR, T lymphocytes, thymic development, adaptor proteins, T cell activation, CAR-T signaling
Citation: Aguado E, Arbulo-Echevarria MM and Compeer EB (2025) Editorial: Mechanisms of early intracellular signaling in T lymphocytes. Front. Immunol. 16:1638330. doi: 10.3389/fimmu.2025.1638330
Received: 30 May 2025; Accepted: 06 June 2025;
Published: 17 June 2025.
Edited and Reviewed by:
Mariolina Salio, Immunocore, United KingdomCopyright © 2025 Aguado, Arbulo-Echevarria and Compeer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Enrique Aguado, ZW5yaXF1ZS5hZ3VhZG9AdWNhLmVz; Ewoud B. Compeer, ZXdvdWQuY29tcGVlckBrZW5uZWR5Lm94LmFjLnVr